Press "Enter" to skip to content

FDA revokes emergency use authorization of hydroxychloroquine for COVID-19


Virus Outbreak Malaria Drug-States

The U.S. Food and Drug Administration on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump.

Source link

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *